An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats
Abstract Early in the SARS-CoV-2 pandemic concerns were raised regarding infection of new animal hosts and the effect on viral epidemiology. Infection of other animals could be detrimental by causing clinical disease, allowing further mutations, and bares the risk for the establishment of a non-huma...
Main Authors: | Martijn A. Langereis, Irina C. Albulescu, Judith Stammen-Vogelzangs, Morindy Lambregts, Ken Stachura, Suzan Miller, Angela M. Bosco-Lauth, Airn E. Hartwig, Stephanie M. Porter, Michelle Allen, Mark Mogler, Frank J. M. van Kuppeveld, Berend-Jan Bosch, Paul Vermeij, Ad de Groof, Richard A. Bowen, Randy Davis, Zach Xu, Ian Tarpey |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-10-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00390-9 |
Similar Items
-
The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon.
by: Maria L Knudsen, et al.
Published: (2013-01-01) -
Oncolytic alphavirus replicons mediated recruitment and activation of T cells
by: Darshak K. Bhatt, et al.
Published: (2024-03-01) -
Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1.
by: Nordström, E, et al.
Published: (2005) -
Rapid, specific detection of alphaviruses from tissue cultures using a replicon-defective reporter gene assay.
by: Jiangjiao Li, et al.
Published: (2012-01-01) -
Correction: Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay
Published: (2012-01-01)